WSFG
PRCT icon

Wall Street Financial Group’s Procept Biorobotics PRCT Stock Holding History

Wall Street Financial Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-70
Closed -$1.75K – 491
2026
Q1 		$1.75K Buy
+70
New +$1.97K ﹤0.01% 565

Other funds holding PRCT

CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
FRA
Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
RAM
Robocap Asset Management London, United Kingdom $124M AUM 95% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
GITFIT
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) Warsaw, Poland $249M AUM 37.04% 1-Year Est. Return
KCM
KRS Capital Management Bloomfield, Michigan $215M AUM 69.3% 1-Year Est. Return

Wall Street Financial Group's PRCT Position: Q2 2026 in Review

Wall Street Financial Group sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 70 shares — an estimated $1.75K sold.

Wall Street Financial Group first reported a position in PRCT in Q1 2026 and held it in 1 quarter. The position peaked at $1.75K in Q1 2026. 49 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Wall Street Financial Group reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Wall Street Financial Group sold 70 Procept Biorobotics shares in Q2 2026, an estimated $1.75K.
  • Wall Street Financial Group first reported a position in Procept Biorobotics in Q1 2026 and held it in 1 quarter.
  • Wall Street Financial Group's Procept Biorobotics position peaked at $1.75K in Q1 2026.
  • 49 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.